← back to search

Lixin Liu

Chinese Academy of Medical Sciences & Peking Union Medical College · CN
Area of research
Epidemiology · Immunology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Immune Response and Inflammation, Liver physiology and pathology, and Sphingolipid Metabolism and Signaling.
h-index
28
citations
2,593
works
94
NIH funding
primary concept
email

Recent publications

Immunoregulatory role of the gut microbiota in inflammatory depression
Nature Communications 2024cited by 203position: middledoi
Characteristics of gut microbiota and its correlation with hs-CRP and somatic symptoms in first-episode treatment-naive major depressive disorder
Journal of Affective Disorders 2024cited by 15position: middledoi
Correction: FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation
Journal of Neuroimmune Pharmacology 2024cited by 0position: middledoi
Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis
Life Sciences 2023cited by 19position: lastdoi
Human Umbilical Cord Mesenchymal Stem Cells' Cultivation and Treatmentof Liver Diseases
Current Stem Cell Research & Therapy 2022cited by 7position: middledoi
SNX10‐mediated LPS sensing causes intestinal barrier dysfunction via a caspase‐5‐dependent signaling cascade
The EMBO Journal 2021cited by 72position: middledoi
Sorting Nexin 10 Mediates Metabolic Reprogramming of Macrophages in Atherosclerosis Through the Lyn-Dependent TFEB Signaling Pathway
Circulation Research 2020cited by 66position: middledoi
SNX10 (sorting nexin 10) inhibits colorectal cancer initiation and progression by controlling autophagic degradation of SRC
Autophagy 2019cited by 66position: middledoi
Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2–STAT3 signaling pathway
Phytomedicine 2019cited by 63position: middledoi
FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation
Journal of Neuroimmune Pharmacology 2019cited by 62position: middledoi
IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway
Biomedicine & Pharmacotherapy 2019cited by 55position: lastdoi
RETRACTED ARTICLE: Insulin-Like Growth Factor Binding Protein-Related Protein 1 Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the PI3K/Akt/mTOR Signaling Pathway
Digestive Diseases and Sciences 2019cited by 22position: lastdoi
SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy
Journal of Hepatology 2018cited by 94position: middledoi
Redirecting TGF-β Signaling through the β-Catenin/Foxo Complex Prevents Kidney Fibrosis
Journal of the American Society of Nephrology 2017cited by 76position: middledoi
Interaction between insulin-like growth factor binding protein-related protein 1 and transforming growth factor beta 1 in primary hepatic stellate cells
Hepatobiliary & pancreatic diseases international 2017cited by 17position: lastdoi
The role of intestinal endotoxemia in a rat model of aluminum neurotoxicity
Molecular Medicine Reports 2017cited by 8position: middledoi
Screening for and validation of a hepatic fibrosis-related pathway induced by insulin-like growth factor-binding protein-related protein 1
European Journal of Gastroenterology & Hepatology 2016cited by 12position: lastdoi
Insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) contributes to liver inflammation and fibrosis via activation of the ERK1/2 pathway
Hepatology International 2014cited by 22position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Qianqian Zhang · Xuzhou Medical College6 papers (2014–2023)Xiaohong Guo · Shanxi Medical University5 papers (2014–2019)Weilian Bao · Fudan University4 papers (2018–2021)Xiaoyan Shen · Hunan University4 papers (2018–2021)Yan You · Fudan University4 papers (2018–2021)Huiqin Fan · Shanxi Medical University3 papers (2017–2019)Wenzhen Dang · Fudan University3 papers (2019–2020)Mingyue Zheng · University of Technology Sydney3 papers (2019–2021)Sulin Zhang · Fudan University3 papers (2019–2021)Hualiang Jiang · Guangzhou University of Chinese Medicine2 papers (2019–2020)Zhifen Liu · Guangzhou University of Chinese Medicine2 papers (2024–2024)Longjun Li · University of Alabama at Birmingham2 papers (2019–2024)Guoping Zheng · The University of Sydney2 papers (2014–2017)Kutty Selva Nandakumar · Southern Medical University2 papers (2019–2019)Penghong Liu · Shanxi Medical University2 papers (2024–2024)Kerang Zhang · Shanxi Medical University2 papers (2024–2024)Yangyang Kong · University of Electronic Science and Technology of China2 papers (2019–2019)Keqi Zhang · Anhui University of Technology2 papers (2019–2024)Xin Sun · Central Hospital of Zibo2 papers (2019–2024)Haiyan Zhang · Xuzhou Medical College2 papers (2017–2019)